# Managing advanced prostate cancer with Viadur (leuprolide acetate implant).

> PubMed lists PMID 11998504 in Urologic nursing as Journal Article, Review, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-11998504-leuprolide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-11998504-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-11998504-leuprolide-v1.json
- Content SHA-256: `6babfd862f069cc08934c20d79e137007a4ba5301a7418baf89b6fa803bc7dfb`

## Claims and source pins

### Headline

Managing advanced prostate cancer with Viadur (leuprolide acetate implant). ([`pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f`](#source-pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f))

### Summary

PubMed lists PMID 11998504 in Urologic nursing as Journal Article, Review, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f`](#source-pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f))

### Paragraph 1

PubMed lists PMID 11998504 in Urologic nursing as Journal Article, Review, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f`](#source-pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f`](#source-pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f))

## Sources

<a id="source-pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f"></a>
- **Managing advanced prostate cancer with Viadur (leuprolide acetate implant). · retained source version 1:2013-11-21:current:3adabdf22c4f0074878ebf878a390990d29a9ce5c084ca9b645f1c772165b15c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/11998504/) (`pubmed-observation-pmid-11998504-2013-11-21-3adabdf22c4f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Managing advanced prostate cancer with Viadur (leuprolide acetate implant)." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-11998504-leuprolide-v1.json SHA-256: 6babfd862f069cc08934c20d79e137007a4ba5301a7418baf89b6fa803bc7dfb.